discontinue if weight loss is less than 5% Regular weight measurements and BMI calculations Monitoring for adverse effects, particularly gastrointestinal symptoms Blood pressure and cardiovascular risk factor assessment Periodic blood tests to monitor metabolic parameters For patients with diabetes who are taking insulin or sulfonylureas, doses of these medications may need to be reduced when starting GLP-1 receptor agonists to prevent hypoglycaemia
N Engl J Med 382:24932503
PlexusDx medications are always compounded in licensed 503A pharmacies and tracked through professional pharmacy networks
(PubMed) Buijsse B, Jacobs DR, Jr., Steffen LM, Kromhout D, Gross MD
We find that, in contrast to previous studies, liver-specific GCLC expression in adult mice is not responsible for maintaining liver survival but instead sustains the expression of lipogenic enzymes and the abundance of triglycerides in the body
doi:10.1016/j.neuron.2008.01.003 119